The European Cannabis Report: 7th Edition
*Please note: Market sizing analysis is not included in the free-to-download version of the report. For market sizing, please see the Premium Packages tab below.
The European Cannabis Report: 7th Edition
*Please note: Market sizing analysis is not included in the free-to-download version of the report. For market sizing, please see the Premium Packages tab below.
Overview
2021 was another huge year for the liberalisation and mainstreaming of cannabis in Europe. Legislation, regulations and market developments continued to evolve for the better. Many countries continued to improve their medical cannabis access schemes, and Prohibition Partners estimates that €354 million worth of unlicensed medical cannabis will be sold in Europe in 2022, and this could reach to €2.3 billion in 2026.
CBD products are continuing their path towards recognition as fully-legal consumer packaged goods (CPGs). As of 2022, several novel foods applications for CBD have been validated by the European Commission.
But, the story which is drawing most international attention is the upcoming liberalisation of adult-use cannabis in Europe, with the ruling coalition of Germany promising full legalisation and commercialisation of adult-use cannabis in this legislative term. Legal sales are set to start in Switzerland by the end of 2022 followed shortly by those in the Netherlands.
Market Sizing
- Unlicensed Medical Cannabis Sales in Europe
- Projected Sales of Adult Use Cannabis in Europe
- CBD Sales in Europe
- Country Focus
Expert Interviews
- Benedikt Sons, Cansativa Group
- Jakob Sons, Cansativa Group
- Timo Bongartz, Fluence EMEA
- Dr Anne Schlag, Project Twenty21
- Bek Muslimov & Nikolay Tretiyakov, Leafy Tunnel
- Denise Fatischek, Tilray
CBD
- Fragmented European Markets
- CBD Legislation in Europe
- CBD as a Cosmetic
- CBD as a Medicine
- Ingestible CBD
- CBD Flowers
Trends
- Medical Cannabis
- Pilot Trials
- Supply Chain
- Product Shortages in Europe
- Countries Allowing Cultivation in Europe
- Patients and Products
- Expert Interviews
Country Focus
- Germany
- Italy
- The Netherlands
- Poland
- United Kingdom
- Switzerland
- Czechia
Key Findings
- Prohibition Partners estimates that, in 2022, 100,000 additional patients will be able to access medical cannabis products in Europe for the first time, bringing the total number of patients to 341,595
- Prohibition Partners predicts that sales of adult-use cannabis in Europe could reach €1.5 billion by 2026, but this forecast is dependent on swift progress and full implementation of adult-use legalisation in Germany.
- Prohibition Partners project €357 million of unlicensed cannabis medicines will be sold in Europe in 2022, growing to €2.3 billion by 2026.
- The German medical market continues to grow steadily, with a 43% increase in sales of cannabis to pharmacies in 2021 (majority sold to patients on private prescriptions).
- In England, the number of unlicensed medical cannabis products dispensed for private prescription grew by 425% to an annual 23,466 products.
- The UK market could constitute about a quarter of the European medical cannabis market by 2026, or €544 million.
- North American cannabis operators remain heavily invested in Europe, with hundreds of millions of euros worth of assets on the continent.
- Operators in at least 15 European countries are now cultivating medical cannabis for commercial purposes.
Package 1 - Market Sizing Data - £1800
This data bolt-on includes market sizing forecasts up until 2026, the number of medical cannabis patients per country, and the driving forces behind growth in key markets.
Package 2 - Adult-Use Cannabis in Europe™ Report - £1800
This additional 25-page report includes: European adult-use market sizing forecasts up until 2026, including several scenarios for the incoming market in Germany; a deep dive into the driving forces behind the market opportunity; an overview of the legislation and regulations guiding new adult-use markets; and a deep dive on the timelines for legislation, proposed models and business opportunities for key adult-use markets over the next five years.
Package 3 - Market Sizing + Adult-Use Cannabis in Europe™ Report - £2990
Save over £600 by purchasing both the Market Sizing and Adult-Use Cannabis in Europe™ Report packages in a single bundle, for the most comprehensive understanding of the European market.
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.